Related Experiment Video
Updated: Jul 2, 2026

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
[Percutaneous aortic aortic valve replacement: myth or reality?]
1Universidade Luterana do Brasil (ULBRA), Porto Alegre, RS, Brasil.
Insights
Transcatheter aortic valve implantation offers a less invasive option for high-risk patients with severe aortic stenosis. This review explores the development and clinical application of this novel treatment, highlighting its potential impact.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Cardiac Surgery
Context:
- Conventional aortic valve replacement (AVR) with extracorporeal circulation is standard for calcific aortic stenosis.
- Elderly patients with comorbidities, reoperations, or severe left ventricular dysfunction face high surgical risks with traditional AVR.
- Percutaneous techniques have emerged as a significant advancement in treating aortic stenosis.
Purpose:
- To review the literature on percutaneous aortic valve implantation (PAVI).
- To trace the development from experimental stages to clinical application of PAVI.
- To assess PAVI as a treatment for patients with severe aortic stenosis and high surgical risk.
Summary:
- Surgical aortic valve replacement is the gold standard for aortic stenosis but carries high risks for certain patient groups.
- Percutaneous aortic valve implantation has been developed as an alternative for high-risk surgical candidates.
- This review analyzes the literature on the evolution and clinical use of PAVI in patients with severe aortic stenosis.
Impact:
- PAVI provides a less invasive therapeutic option for high-risk patients with severe aortic stenosis.
- Cardiovascular surgeons play a crucial role in the development and application of percutaneous aortic valve procedures.
- The adoption of PAVI signifies a paradigm shift in managing complex aortic valve disease.
Abstract:
Aortic valve replacement with mechanical or biological prosthesis with extracorporeal circulation is the gold-standard for the treatment of calcific aortic stenosis. Although the results are excellent with the conventional approach some elderly patients, with multiple high-risk comorbid conditions, reoperations and severe left ventricular dysfunction have high surgical risk. During the last years percutaneous techniques have been developed. The present study aim to analyse the literature, since the experimental development until clinical application of this novel treatment in patients with high surgical risk aortic stenosis. Percutaneous implantation of aortic valve prosthesis is being done in some centers and the cardiovascular surgeon that treats valve disease should be involved in this development.
Related Concept Videos
Aortic Regurgitation III: Medical Management
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic Regurgitation I: Introduction
